NRC Health Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value
NRC Health (NRC) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value of $6.55 million for the 9-month period ending 2019-09-30, per its 10-Q filed 2019-11-08.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue · last filed 2019-11-08
- NRC Health share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2019-09-30 was $3.14M.
- NRC Health share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2019-06-30 was $691.00K.
- NRC Health share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2019-03-31 was $2.72M.
- NRC Health share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2012 was $6.60M, a 560.00% increase from fiscal 2011.
- NRC Health share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2011 was $1.00M, a 420.83% increase from fiscal 2010.
- NRC Health share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2010 was $192.00K.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 12 month |
|---|---|---|---|---|
| 2019-09-30 | $3.14M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | $3.83M derived: sum of 2 quarters · filed 2019-11-08 | $6.55M 10-Q · filed 2019-11-08 | |
| 2019-06-30 | $691.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $3.41M 10-Q · filed 2019-08-08 | ||
| 2019-03-31 | $2.72M 10-Q · filed 2019-05-08 | |||
| 2018-06-30 | $5.94M 10-Q · filed 2018-08-09 | |||
| 2012-12-31 | $6.60M 10-K · filed 2013-03-01 | |||
| 2011-12-31 | $1.00M 10-K · filed 2013-03-01 | |||
| 2010-12-31 | $192.00K 10-K · filed 2013-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |